Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
Globenewswire· 2025-11-08 05:30
Presented data underscore the potential of lasme-cel (UCART22) and eti-cel (UCART20x22) to improve outcomes in r/r B-ALL and r/r NHL: Lasme-cel in r/r B-ALL (BALLI-01) ORR of 68% with lasme-cel Process 2 (n=22), 83% at RP2D (n=12) and 100% in the target Phase 2 population (n=9)Median OS of 14.8 months in patients who achieved MRD-negative CR/CRi First interim analysis for the BALLI-01 trial expected in Q4 2026 Eti-cel in r/r NHL (NATHALI-01) ORR of 86% and 57% CR rate (n=7)Development update to be presen ...
Cannabix Technologies announces Non-Brokered LIFE Private Placement
Globenewswire· 2025-11-08 05:30
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORFOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (the “Company or Cannabix”) announces a non-brokered private placement for a minimum of 2,127,659 units (the "Units") of the Company at a price of C$0.47 per Unit for aggregate gross proceeds to the Company of $1,000,000 and up to a maximum of 4,255,319 Units for aggregate gross proceeds of $2,000,000 (the "Offe ...
Nextech3D.ai and Arway Provide Business Combination Update
Accessnewswire· 2025-11-08 05:30
TORONTO, ON / ACCESS Newswire / November 7, 2025 / Nextech3D.AI (the "Company" or "Nextech") (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2) and Arway Corporation ("Arway") (OTCQB:ARWYF) (CSE:ARWY) are pleased to provide an update today at the request of staff of the Ontario Securities Commission in connection with a continuous disclosure review, with regard to the previously announced transaction pursuant to which Nextech proposes to acquire all of the common shares of Arway which it does not already own (the "Transactio ...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - ORIC Pharmaceuticals (NASDAQ:ORIC)
Benzinga· 2025-11-08 05:30
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on November 3, 2025 (the "Grant Date"), ORIC granted a total of 18,400 non-qualified stock options and 3,000 restricted stock units to one new non-executive employee who began their employment with ORIC in October 2025.These inducement grants were grante ...
The New Home Company Schedules Earnings Conference Call for the Fiscal 2025 Fourth Quarter
Businesswire· 2025-11-08 05:30
IRVINE, Calif.--(BUSINESS WIRE)--The New Home Company today announced that the Company will release its financial results for the fiscal 2025 fourth quarter on its confidential data site on Thursday, November 13, 2025. The Company will also host a conference call beginning at 8:00 AM Pacific Time (11:00 AM Eastern Time) on Thursday, November 13, 2025 to review the results, discuss recent events and conduct a question-and- answer period. The earnings release, investor presentation, conference call and webcas ...
KKR outlines confidence in $4.50+ FRE and $7+ ANI per share guidance for 2026 amid record fundraising and monetization pipeline (NYSE:KKR)
Seeking Alpha· 2025-11-08 05:27
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Ares Commercial Real Estate targets portfolio growth in first half of 2026 amid accelerated capital deployment and loan resolutions (NYSE:ACRE)
Seeking Alpha· 2025-11-08 05:26
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
宁波太平鸟时尚服饰股份有限公司关于不向下修正“太平转债”转股价格的公告
上海证券报· 2025-11-08 05:25
证券代码:603877 证券简称:太平鸟 公告编号:2025-094 债券代码:113627 债券简称:太平转债 宁波太平鸟时尚服饰股份有限公司关于不向下修正"太平转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 截至2025年11月7日,宁波太平鸟时尚服饰股份有限公司(以下简称"公司")股票在任意连续三十个 交易日中有十五个交易日的收盘价格低于当期转股价格的85%,触发"太平转债"转股价格向下修正条 款。 ● 经公司第五届董事会第八次会议审议通过,公司董事会决定本次不向下修正"太平转债"转股价格,同 时在未来十二个月内(2025年11月8日至2026年11月7日),如再次触发"太平转债"转股价格向下修正条 款,亦不提出向下修正方案。在此之后,若再次触发"太平转债"转股价格向下修正条款,届时公司董事 会将再次召开会议决定是否行使"太平转债"的转股价格向下修正权利。 一、"太平转债"基本情况 经中国证券监督管理委员会《关于核准宁波太平鸟时尚服饰股份有限公司公开发行可转换公司债券的批 复》( ...
无锡祥生医疗科技股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告
上海证券报· 2025-11-08 05:25
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688358 证券简称:祥生医疗公告编号:2025-042 无锡祥生医疗科技股份有限公司 关于持股5%以上股东权益变动触及1%刻度的提示性公告 ■ 一、信息披露义务人及其一致行动人的基本信息 1.身份类别 ■ 2.信息披露义务人信息 ■ 股东莫若理女士及其一致行动人无锡祥生投资有限公司、无锡祥鼎投资企业(有限合伙)、无锡祥同投 资企业(有限合伙)、上海御德科技有限公司保证向本公司提供的信息真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 3.一致行动人信息 ■ 注:公司实际控制人莫善珏、莫若理和陆坚系一致行动人,莫若理控制无锡祥生投资有限公司,陆坚控 制无锡祥鼎投资企业(有限合伙)、无锡祥同投资企业(有限合伙)和上海御德科技有限公司。 二、权益变动触及1%刻度的基本情况 无锡祥生医疗科技股份有限公司(以下简称"公司")于近日收到公司股东莫若理女士发来的《关于无锡 祥生医疗科技股份有限公司股东减持股份计划实施进展暨权益变动触及1%刻度的告知函》。莫若理女 士于2 ...
Why Stocks Will Keep Rising Even While Investors Stay Nervous
ZACKS· 2025-11-08 05:25
Have you ever hung out with two people with two different reactions to the same circumstance? For instance, imagine that you’re at a college football game, the weather sours, and the rain begins to pour down. One person may get a negative attitude and become frustrated that their clothes are getting wet. Conversely, another person may embrace the rain, with the mindset that the inclement weather may add some excitement to the game while also understanding that rain is just not that bad. After all, most of u ...